Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do we need the third-generation cephalosporins?

H C Neu

    The Journal of Antimicrobial Chemotherapy
    |September 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Third-generation cephalosporins offer effective treatment for various infections, including respiratory and urinary tract infections, especially in the elderly. Careful monitoring for resistance is crucial, as some bacteria can develop resistance to these valuable antimicrobial agents.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Postantibiotic effect of ceftibuten on respiratory pathogens.

    The Pediatric infectious disease journal·1995
    Same author

    Ceftibuten: minimal inhibitory concentrations, postantibiotic effect and beta-lactamase stability--a rationale for dosing programs.

    The Pediatric infectious disease journal·1995
    Same author

    In vitro activity of SCE-2787, a new cephalosporin with potent activity against Pseudomonas aeruginosa and members of the family Enterobacteriaceae.

    Antimicrobial agents and chemotherapy·1994
    Same author

    Emerging trends in antimicrobial resistance in surgical infections. A review.

    The European journal of surgery. Supplement. : = Acta chirurgica. Supplement·1994
    Same author

    Synergy and antagonism of fluoroquinolones with other classes of antimicrobial agents.

    Drugs·1993
    Same author

    Gemfibrozil enhances the listeriacidal effects of fluoroquinolone antibiotics in J774 macrophages.

    The Journal of experimental medicine·1992
    Same journal

    β-lactam susceptibility testing of ampicillin-susceptible non-faecalis enterococcal clinical isolates in France.

    The Journal of antimicrobial chemotherapy·2026
    Same journal

    Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing.

    The Journal of antimicrobial chemotherapy·2026
    Same journal

    A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa.

    The Journal of antimicrobial chemotherapy·2026
    Same journal

    Incidence and factors associated with subtherapeutic cefazolin levels among patients with severe infections.

    The Journal of antimicrobial chemotherapy·2026
    Same journal

    Emerging resistance in staphylococci following long-term dalbavancin treatment for prosthetic joint infections.

    The Journal of antimicrobial chemotherapy·2026
    Same journal

    Microbiology testing around the time of antibiotic initiation among residents of long-term care facilities.

    The Journal of antimicrobial chemotherapy·2026
    See all related articles

    Area of Science:

    • Pharmacology and Infectious Diseases

    Background:

    • Third-generation cephalosporins are increasingly important due to rising resistance to older antibiotics.
    • Their favorable safety profiles enhance their clinical utility.

    Purpose of the Study:

    • To review the established and potential applications of third-generation cephalosporins.
    • To highlight their efficacy in specific bacterial infections and patient populations.

    Main Methods:

    • Review of clinical applications and microbiological data for third-generation cephalosporins.
    • Comparison with older antimicrobial agents and assessment of safety profiles.

    Main Results:

    • Preferred agents for upper respiratory infections (e.g., epiglottitis) and Enterobacteriaceae lower respiratory tract infections.

    Related Experiment Videos

  • Effective for bone and joint infections due to Enterobacteriaceae, with lower toxicity than aminoglycosides.
  • Key therapy for meningitis in the elderly (E. coli, K. pneumoniae) and alternative for neonatal meningitis.
  • Highly effective against penicillinase-producing Neisseria gonorrhoeae.
  • Beneficial for hospital-acquired urinary tract infections in the elderly due to good urinary levels and low nephrotoxicity.

    • Conclusions:

    • Third-generation cephalosporins are valuable for specific infections, offering advantages over older drugs.
    • Their role in gynecological and intra-abdominal infections requires further clarification.
    • Ongoing surveillance for resistance in species like Enterobacter, Serratia, and Citrobacter is essential.